Could Vaccination against COVID-19 Trigger Immune-Mediated Inflammatory Diseases?

被引：0

作者：

Liakou, Aikaterini I. ^{[1
]}

Tsantes, Andreas G. ^{[2
,3
]}

Routsi, Eleni ^{[1
]}

Agiasofitou, Efthymia ^{[1
]}

Kalamata, Magdalini ^{[1
]}

Bompou, Evangelia-Konstantina ^{[1
]}

Tsante, Konstantina A. ^{[2
]}

Vladeni, Soultana ^{[1
]}

Chatzidimitriou, Eleni ^{[1
]}

Kotsafti, Ourania ^{[1
]}

Samonis, George ^{[4
,5
]}

Bonovas, Stefanos ^{[6
,7
]}

Stratigos, Alexander I. ^{[1
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Andreas Sygros Hosp, Med Sch, Dept Dermatol Venereol 1, Athens 16121, Greece

[2] Natl & Kapodistrian Univ Athens, Attikon Hosp, Med Sch, Lab Haematol & Blood Bank Unit, Athens 12462, Greece

[3] St Savvas Oncol Hosp, Microbiol Dept, Athens 11522, Greece

[4] Univ Crete, Dept Med, Iraklion 71500, Greece

[5] Metropolitan Hosp, Dept Oncol, Athens 18547, Greece

[6] Humanitas Univ, Dept Biomed Sci, I-20072 Milan, Italy

[7] IRCCS, Humanitas Res Hosp, Milan, Italy

来源：

JOURNAL OF CLINICAL MEDICINE | 2024年 / 13卷 / 16期

关键词：

immune-mediated inflammatory diseases; COVID-19; vaccine; flare; onset; hidradenitis;

D O I：

10.3390/jcm13164617

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Exacerbations and new onset of immune-mediated inflammatory diseases, such as psoriasis and hidradenitis suppurativa, have been reported following COVID-19 vaccination. In patients with hidradenitis suppurativa, recent studies have shown that those who received mRNA vaccines were 3.5 times as likely to develop flares following vaccination compared to patients who received non-mRNA vaccines, indicating that mRNA COVID-19 vaccines are associated with hidradenitis suppurativa flares. Similar findings have been found in other studies evaluating the association between COVID-19 vaccines and other immune-mediated inflammatory diseases such as psoriasis, atopic dermatitis, lichen planus, and alopecia areata. However, further research is warranted in larger populations to validate these findings.

引用

页数：10

共 50 条

[21] Immunogenicity After Primary COVID-19 Vaccination in Patients with Immune-mediated Inflammatory Diseases: A Comparative Cohort Study
Kastrati, Kastriot
Mrak, Daniel
Weber, Peter
Goethans, Lena
Hana, Claudia
Simader, Elisabeth
Hummel, Thomas
Friedberg, Eleonora
Aletaha, Daniel
Bonelli, Michael
Radner, Helga
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2383 - 2385
[22] How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group
Ferretti, Francesca
Cannatelli, Rosanna
Benucci, Maurizio
Carmagnola, Stefania
Clementi, Emilio
Danelli, Piergiorgio
Dilillo, Dario
Fiorina, Paolo
Galli, Massimo
Gallieni, Maurizio
Genovese, Giovanni
Giorgi, Valeria
Invernizzi, Alessandro
Maconi, Giovanni
Maier, Jeanette A.
Marzano, Angelo V.
Morpurgo, Paola S.
Nebuloni, Manuela
Radovanovic, Dejan
Riva, Agostino
Rizzardini, Giuliano
Sabiu, Gianmarco
Santus, Pierachille
Staurenghi, Giovanni
Zuccotti, Gianvincenzo
Sarzi-Puttini, Pier Carlo
Ardizzone, Sandro
FRONTIERS IN IMMUNOLOGY, 2021, 12
[23] COVID-19 vaccination in patients with immune-mediated inflammatory diseases receiving rituximab: A personalized regimen should be formulated
Yang, Qian
Jiang, Qi
Niu, Man Man
Fan, Guo Zhen
Hu, Peng
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (01) : E45 - E46
[24] IMMUNE RESPONSE AFTER COVID-19 VACCINATION DURING MAINTANACE THERAPY IN IMMUNE-MEDIATED INFLAMMATORY DISEASES: AN OBSERVATIONAL COHORT STUDY
Dayam, R. M.
Law, Jaclyn C.
Goetgebuer, Rogier
Chao, Gary
Stempak, Joanne M.
Pereira, Daniel
Acheampong, Lily
Rizwan, Saima
Milgrom, Raquel
Rymaszewski, Klaudia
Ganatra, Darshini
Finkelstein, Naomi
Croitoru, David
Lau, Irene
Law, Ryan
Girard, Melanie
Batista, Nathalia Vieira
Abe, Kento
Rathod, Bhavisha
Kitaygorodski, Julia
Piguet, Vincent
Chandran, Vinod
Silverberg, Mark S.
Gingras, Anne-Claude
Watts, Tania
GASTROENTEROLOGY, 2022, 162 (07) : S1006 - S1006
[25] COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
Fagni, Filippo
Simon, David
Tascilar, Koray
Schoenau, Verena
Sticherling, Michael
Neurath, Markus F.
Schett, Georg
LANCET RHEUMATOLOGY, 2021, 3 (10): : E724 - E736
[26] Immune-mediated liver injury following COVID-19 vaccination
Georgios Schinas
Eleni Polyzou
Vasiliki Dimakopoulou
Stamatia Tsoupra
Charalambos Gogos
Karolina Akinosoglou
World Journal of Virology, 2023, (02) : 100 - 108
[27] COVID-19 vaccine confidence in the post-vaccination era: Perceptions among adults with immune-mediated inflammatory diseases
Santana, F. M.
Rezende, R. P. V.
Paschoal, N. O. S.
Rocha, L. F.
Lopes, J. B.
Perez, M. O.
Bunjes, B. G.
Dorio, M.
Furquim, M. A. D.
Cobra, J. F.
Sales, L. P.
Figueiredo, C. P.
PUBLIC HEALTH IN PRACTICE, 2023, 6
[28] Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York
Haberman, Rebecca
Axelrad, Jordan
Chen, Alan
Castillo, Rochelle
Yan, Di
Izmirly, Peter
Neimann, Andrea
Adhikari, Samrachana
Hudesman, David
Scher, Jose U.
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (01): : 85 - 88
[29] Immunogenicity and Efficacy of Mixed COVID-19 Vaccine Regimens in Immune-Mediated Inflammatory Diseases
Hitchon, Carol
Mesa, Christine
Bernstein, Charles
Card, Catherine
Marrie, Ruth
OBrien, Sheila
Kim, John
JOURNAL OF RHEUMATOLOGY, 2023, 50 (07) : 49 - 50
[30] Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak
Veenstra, Jesse
Buechler, Connor R.
Robinson, Gabrielle
Chapman, Stephanie
Adelman, Madeline
Tisack, Aaron
Dimitrion, Peter
Todter, Erika
Kohen, Laurie
Lim, Henry W.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : 1696 - 1703

← 1 2 3 4 5 →